These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2049682)

  • 21. Sudden cardiac death: the major challenge confronting contemporary cardiology.
    Lown B
    Am J Cardiol; 1979 Feb; 43(2):313-28. PubMed ID: 83793
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiarrhythmic drugs in cardiac arrest resuscitation: intravenous amiodarone or intravenous lidocaine?
    Singh BN
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):61-4. PubMed ID: 12075393
    [No Abstract]   [Full Text] [Related]  

  • 23. [Protocol-guide in clinical experimentation on anti-arrhythmia agents].
    Tavazzi L; Sanna GP; Tognoni G; Rizzon P
    G Ital Cardiol; 1985 Jul; 15(7):711-7. PubMed ID: 4076706
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ventricular arrhythmias and sudden death: diagnostic, prognostic and therapeutic aspects].
    Van Durme JP
    Verh K Acad Geneeskd Belg; 1981; 43(3):129-84. PubMed ID: 7336827
    [No Abstract]   [Full Text] [Related]  

  • 25. Sudden cardiac death: risk, evaluation, and primary prevention.
    Tommaso CL; Kehoe RF
    Geriatrics; 1983 Jul; 38(7):42-8, 53. PubMed ID: 6852538
    [No Abstract]   [Full Text] [Related]  

  • 26. [Arrhythmia as risk factor].
    Internist (Berl); 1997 Feb; 38(2 Suppl Risikofakt):1-8. PubMed ID: 9330651
    [No Abstract]   [Full Text] [Related]  

  • 27. [Implantable automatic defibrillator after MADIT and EMIAT].
    Farré J
    Rev Esp Cardiol; 1996 Oct; 49(10):709-13. PubMed ID: 9036472
    [No Abstract]   [Full Text] [Related]  

  • 28. [Amiodarone in the treatment of arrhythmias].
    Raatikainen MJ; Huikuri HV
    Duodecim; 1998; 114(19):1923-36. PubMed ID: 11717746
    [No Abstract]   [Full Text] [Related]  

  • 29. What have clinical trials taught us about proarrhythmia?
    Skanes AC; Green MS
    Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone: a late comer.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Amiodarone in the nineties: to whom and what dosage?].
    Moro Serrano C; Hernández Madrid A; Lage Silveira J; Vivas Alvarez E; Kanjhi M
    Rev Esp Cardiol; 1995 Apr; 48(4):272-84. PubMed ID: 7740149
    [No Abstract]   [Full Text] [Related]  

  • 32. Sudden death--how can we prevent it?
    Heart Lung; 1979; 8(3):568-74. PubMed ID: 254682
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical use of intravenous amiodarone for supraventricular arrhythmias].
    Assadi S; Edoute Y
    Harefuah; 1995 Dec; 129(12):583-6. PubMed ID: 8682364
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ventricular arrhythmias: diagnosis and drug therapy].
    Schüpfer C; Gertsch M
    Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are implantable cardioverter-defibrillators or drugs more effective in prolonging life? The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial Executive Committee.
    Am J Cardiol; 1997 Mar; 79(5):661-3. PubMed ID: 9068527
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in the treatment of malignant ventricular arrhythmias: new hope for prolonged survival.
    Bissett JK; Sharma B; Franciosa JA
    J Ark Med Soc; 1985 May; 81(12):635-9. PubMed ID: 2975648
    [No Abstract]   [Full Text] [Related]  

  • 38. Ventricular arrhythmia induction study.
    Freedman RA; Mason JW
    Cardiovasc Clin; 1985; 15(1):215-29. PubMed ID: 3842328
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
    Brachmann J
    Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.